Editorial: Reducing ventilator-associated pneumonia: When process control allows outcome improvement and even benchmarking

Critical Care Medicine

Volumn 38, Issue 3, 2010, Pages 983-984

  Pittet, Didier ^a   Zingg, Walter ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Benchmarking; Bundle; Intervention; Practice improvement; Prevention; Process control; Quality indicators; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE;

EDITORIAL; HEALTH CARE COST; HUMAN; HYGIENE; INTENSIVE CARE; LENGTH OF STAY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; VENTILATOR ASSOCIATED PNEUMONIA; DIAGNOSIS RELATED GROUP; HEALTH CARE QUALITY; NOTE; QUALITY CONTROL; RISK FACTOR; STANDARD; TREATMENT OUTCOME;

BENCHMARKING; CRITICAL CARE; DIAGNOSIS-RELATED GROUPS; HUMANS; HYGIENE; PNEUMONIA, VENTILATOR-ASSOCIATED; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; TREATMENT OUTCOME;

EID: 77249143356     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c8fd0c     Document Type: Editorial

References (16)

1. Edwards JR, Peterson KD, Andrus ML, et al: National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008; 36:609-626
2. Eggimann P, Hugonnet S, Sax H, et al: Ventilator-associated pneumonia: Caveats for benchmarking. Intensive Care Med 2003; 29: 2086-2089
3. Hugonnet S, Eggimann P, Borst F, et al: Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004; 25: 1090-1096
4. Safdar N, Dezfulian C, Collard HR, et al: Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005; 33:2184-2193
5. Warren DK, Shukla SJ, Olsen MA, et al: Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31:1312-1317
6. Bergmans DC, Bonten MJ, Gaillard CA, et al: Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Anti-microb Chemother 1997; 39:527-535
7. Harbarth S, Harris AD, Carmeli Y, et al: Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 33:1462-1468
8. Chastre J: Preventing ventilator-associated pneumonia: Could silver-coated endotra-cheal tubes be the answer? JAMA 2008; 300: 842-844
9. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153:1711-1725
10. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
11. Klompas M, Platt R: Ventilator-associated pneumonia-the wrong quality measure for benchmarking. Ann Int Med 2007; 147: 803-805
12. Uckay I, Ahmed QA, Sax H, et al: Ventilator-associated pneumonia as a quality indicator for patient safety? Clin Infect Dis 2008; 46: 557-563
13. Horan TC, Andrus M, Dudeck MA: CDC/ NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332
14. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
15. Saint S, Meddings JA, Calfee D, et al: Catheter-associated urinary tract infection and the Medicare rule changes. Ann Int Med 2008; 150:877-884
16. Bouadma L, Mourvillier B, Deiler V, et al: A multifaceted program to prevent ventilator-associated pneumonia: Impact on compliance with preventive measures. Crit Care Med 2010;38:789-796